Diabetes Mellitus Community Based Screening in Minority Populations

Summary

The purpose of the type II diabetes (T2D) screening study is to improve diabetes care in minority communities by identifying undiagnosed and uncontrolled T2D patients, as well as help patients without a regular primary care physician (PCP) find one within their community. These goals will be achieved first through a glucose measurement. Individuals with a high glucose measurement will be confirmed with a rapid hemoglobin A1c (HgA1c) test. The HgA1c test will tell us about the patients average blood sugar over the past 3 months, which will allow us to immediately diagnose new and uncontrolled type II diabetics. All participants will fill out a survey on healthcare seeking behaviors before glucose testing. All patients who enter the study will receive education on T2D and the value of regularly visiting their PCP, and will be provided a list of PCP currently accepting new patients within a 3 mile radius. Follow-up visits at 4 and 8 months will help us determine the success this community based screening.

The investigators hypothesis is that community based screening designed with adequate education and follow-up, and performed by qualified medical professionals will improve diabetes care in minority communities as assessed through hemoglobin A1c levels over 8 months, and in the change in the number patients who visit/obtain their PCP within the study period.

Conditions

• Type II Diabetes
• Diabetes Mellitus

Interventions

BEHAVIORAL

Education on risk factors for Type II Diabetes

one-on-one education provided by a nurse practitioner or physician

BEHAVIORAL

Education on Type II Diabetes

one-on-one education about having Type II Diabetes, the possible complications and treatment options provided by a physician.

BEHAVIORAL

Education on regular visits to a Primary Care Provider

one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.

Sponsors & Collaborators

• Steward Carney Hospital

  collaborator UNKNOWN

• Boston Public Housing Authority

  collaborator UNKNOWN

• Ethnicity and Disease Community Empowerment Center

  lead OTHER

Principal Investigators

• Kelly Lamb, MA · Ethnicity and Diseasse Community Empowerment Center

• Jean Bonnet, MD · Ethnicity and Disease Community Empowerment Center

• James Morgan, MD · Steward Carney Hospital

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2012-06-30

Primary Completion

2013-01-31

Completion

2013-01-31

Countries

• United States

Study Locations